Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market
Holding EVAX?
Track your performance easily

Evaxion Biotech (EVAX) Balance Sheet

209 Followers

Evaxion Biotech Balance Sheet

Evaxion Biotech's total assets for Q4 2023 were $12.89M, a decrease of -41.48% from the previous quarter. EVAX total liabilities were $17.62M for the fiscal quarter, a 28.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 12.89M$ 22.02M$ 40.16M$ 11.94M$ 11.08M
Total Liabilities
$ 17.62M$ 13.72M$ 7.73M$ 39.24M$ 1.72M
Total Equity Gross Minority
$ -4.73M$ 8.30M$ 32.40M$ -27.28M$ 9.36M
Total Capitalization
$ 3.76M$ -64.80M$ -49.39M$ -27.28M$ 9.36M
Preferred Stock Equity
-----
Capital Lease Obligations
----$ 36.00K
Currency in USD

Evaxion Biotech Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis